- 首頁
- 科研細(xì)胞
- 藥靶模型
-
診斷試劑
腫瘤早篩甲基化標(biāo)準(zhǔn)品
遺傳性基因標(biāo)準(zhǔn)品
優(yōu)生優(yōu)育標(biāo)準(zhǔn)品
HLA標(biāo)準(zhǔn)品
數(shù)字PCR
- 技術(shù)服務(wù)
- 新聞中心
- 資源中心
- 關(guān)于我們
- 聯(lián)系我們
科研細(xì)胞
Research cells
CBP60632
I. General information | |
Synonyms: | DB |
Background: | The DB cell line was established by Walter J. Urba and Dan L. Longo from ascites fluid from a patient with a diffuse large cell lymphoma. |
Species: | Homo sapiens, human |
Tissue: | Ascites |
Disease: | large cell lymphoma |
Gender: | Caucasian,male,45 years |
Morphology: | lymphoblast |
Growth Mode: | suspension |
DNA Profile: | Amelogenin: X,Y CSF1PO: 10,11 D13S317: 11,12 D16S539: 11 D5S818: 11 D7S820: 11 THO1: 6,8 TPOX: 8 vWA: 15,16 Cobioer’s Cell Line Authentication Service |
Culture Medium: |
RPMI-1640+10%FBS DB完全培養(yǎng)基,# CBP60632M |
Cryopreservation medium: | 90%FBS+10%DMSO |
Antigen Expression: | CD19 +; CD20 +; CD22 +; Hle-1 +; CD21 -; CD25 - |
Cellular Products: | immunoglobulin |
Comments: | The cells do not express HLA-DR, HLA-DQ, IgM , IgD or T cell rantigen receptor. Exposure of DB cells to phorbol esters (PMA or PdBu) that activate protein kinase C results in profound growth inhibition. They are reported to be negative for the Epstein-Barr virus genome.The cells were cured of a prior mycoplasma contamination by a 21 day treatment with BM-cycline. For more information, please contact Cobioer (4008-750-250). |
相關(guān)產(chǎn)品推薦